Methodological and reporting quality of systematic reviews on tuberculosis

International Journal of Tuberculosis and Lung Disease

Volumn 17, Issue 9, 2013, Pages 1160-1169

  Nicolau, I ^a   Ling, D ^a   Tian, L ^b   Lienhardt, C ^c   Pai, M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b EMORY UNIVERSITY   (United States)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Metaanalyses; Methodological quality; Systematic reviews; Tuberculosis

Indexed keywords

ARTICLE; ASSESSMENT OF MULTIPLE SYSTEMATIC REVIEW; CHECKLIST; DATA PROCESSING; EVIDENCE BASED PRACTICE; HEALTH SURVEY; OBSERVATIONAL STUDY; PREFERRED REPORTING ITEMS FOR SYSTEMATIC REVIEWS AND META ANALYSIS; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); STATISTICAL ANALYSIS; STUDY DESIGN; SYSTEMATIC REVIEW (TOPIC); TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 84882968048     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.13.0050     Document Type: Article

References (152)

1. Guyatt G H, Oxman A D, Vist G E, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926.
2. World Health Organization. Treatment of tuberculosis: guidelines. 4th ed. WHO/HTM/TB/2009.420. Geneva, Switzerland: WHO, 2010.
3. World Health Organization. Use of tuberculosis interferongamma release assays (IGRAs) in low-and middle-income countries: policy statement. Geneva, Switzerland: WHO, 2011.
4. World Health Organization. Commercial serodiagnostic tests for diagnosis of tuberculosis: policy statement. WHO/HTM/TB/2011.5. Geneva, Switzerland: WHO, 2011.
5. Lienhardt C, Espinal M, Pai M, Maher D, Raviglione M C. What research is needed to stop TB? Introducing the TB research movement. PLoS Med 2011; 8: e1001135.
6. Nicolau I, Ling D, Tian L, Lienhardt C, Pai M. Research questions and priorities for tuberculosis: a survey of published systematic reviews and meta-analyses. PLoS ONE 2012; 7: e42479.
7. Rylance J, Pai M, Lienhardt C, Garner P. Priorities for tuberculosis research: a systematic review. Lancet Infect Dis 2010; 10: 886-892.
8. Shea B J, Grimshaw J M, Wells G A, et al. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 2007; 7: 10.
9. Moher D, Liberati A, Tetzlaff J, Altman D G. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009; 151: 264-269, W64.
10. World Health Organization, Stop TB Partnership. An international roadmap for tuberculosis research: towards a world free of tuberculosis. Geneva, Switzerland: WHO, 2011.
11. UK Clinical Research Collaboration. Health research classification system. London, UK: UK Clinical Research Collaboration, 2011.
12. Stata Corp. Stata statistical software: release 11. College Station, TX, USA: Stata Corp LP, 2009.
13. Abba K, Sudarsanam T D, Grobler L, Volmink J. Nutritional supplements for people being treated for active tuberculosis. Cochrane Database Syst Rev 2008; (4): CD006086.
14. Abubakar I. Tuberculosis and air travel: a systematic review and analysis of policy. Lancet Infect Dis 2010; 10: 176-183.
15. Agarwal R, Srinivas R, Aggarwal A N. Parenchymal pseudotumoral tuberculosis: case series and systematic review of literature. Respir Med 2008; 102: 382-389.
16. Akolo C, Adetifa I, Shepperd S, Volmink J. Treatment of latent tuberculosis infection in HIV-infected persons. Cochrane Database Syst Rev 2010; (1): CD000171.
17. Arshad S, Bavan L, Gajari K, Paget S N J, Baussano I. Active screening at entry for tuberculosis among new immigrants: a systematic review and meta-analysis. Eur Respir J 2010; 35: 1336-1345.
18. Balcells M E, Thomas S L, Godfrey-Faussett P, Grant A D. Isoniazid preventive therapy and risk for resistant tuberculosis. Emerg Infect Dis 2006; 12: 744-751.
19. Bates M N, Khalakdina A, Pai M, Chang L, Lessa F, Smith K R. Risk of tuberculosis from exposure to tobacco smoke: a systematic review and meta-analysis. Arch Intern Med 2007; 167: 335-342.
20. Bliven E E, Podewils L J. The role of chronic hepatitis in isoniazid hepatotoxicity during treatment for latent tuberculosis infection. Int J Tuberc Lung Dis 2009; 13: 1054-1060.
21. Brasil P E, Braga J U. Meta-analysis of factors related to health services that predict treatment default by tuberculosis patients. Cad Saúde Publica 2008; 24 (Suppl 4): S485-S502.
22. Bwanga F, Hoffner S, Haile M, Joloba M L. Direct susceptibility testing for multi drug resistant tuberculosis: a meta-analysis. BMC Infect Dis 2009; 9: 67.
23. Cattamanchi A, Davis J L, Pai M, Huang L, Hopewell P C, Steingart K R. Does bleach processing increase the accuracy of sputum smear microscopy for diagnosing pulmonary tuberculosis? J Clin Microbiol 2010; 48: 2433-2439.
24. Chang K C, Leung C C. Systematic review of interferon-gamma release assays in tuberculosis: focus on likelihood ratios. Thorax 2010; 65: 271-276.
25. Chang K C, Leung C C, Yew W W, Chan S L, Tam C M. Dosing schedules of 6-month regimens and relapse for pulmonary tuberculosis. Am J Respir Crit Care Med 2006; 174: 1153-1158.
26. Chang K C, Leung E C C, Leung C C. Interferon-gamma release assays in childhood tuberculosis: a systematic review. Hong Kong J Paediatr 2009; 14: 86-95.
27. Chang K C, Yew W W, Chan R C. Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2010; 65: 1551-1561.
28. Chang K C, Yew W W, Zhang Y. A systematic review of rapid drug susceptibility tests for multidrug-resistant tuberculosis using rifampin resistance as a surrogate. Expert Opin Med Diagn 2009; 3: 99-122.
29. Clark R C, Mytton J. Estimating infectious disease in UK asylum seekers and refugees: a systematic review of prevalence studies. J Public Health 2007; 29: 420-428.
30. Cox H S, Morrow M, Deutschmann P W. Long term efficacy of DOTS regimens for tuberculosis: systematic review. BMJ 2008; 336: 484-487.
31. Daley P, Thomas S, Pai M. Nucleic acid amplification tests for the diagnosis of tuberculous lymphadenitis: a systematic review. Int J Tuberc Lung Dis 2007; 11: 1166-1176.
32. Davies G, Cerri S, Richeldi L. Rifabutin for treating pulmonary tuberculosis. Cochrane Database Syst Rev 2007; (4): CD005159.
33. Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952-968.
34. Dinnes J, Deeks J, Kunst H, et al. A systematic review of rapid diagnostic tests for the detection of tuberculosis infection. Health Technol Assess 2007; 11: 1-178.
35. Ena J, Valls V. Short-course therapy with rifampin plus isoniazid, compared with standard therapy with isoniazid, for latent tuberculosis infection: a meta-analysis. Clin Infect Dis 2005; 40: 670-676.
36. Engel M E, Matchaba P T, Volmink J. Corticosteroids for tuberculous pleurisy. Cochrane Database Syst Rev 2007; (4): CD001876.
37. European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerg Infect Dis 2006; 12: 736-743.
38. Farhat M, Greenaway C, Pai M, Menzies D. False-positive tuberculin skin tests: what is the absolute effect of BCG and nontuberculous mycobacteria? Int J Tuberc Lung Dis 2006; 10: 1192-1204.
39. Faustini A, Hall A J, Perucci C A. Tuberculosis treatment outcomes in Europe: a systematic review. Eur Respir J 2005; 26: 503-510.
40. Faustini A, Hall A J, Perucci C A. Risk factors for multidrugresistant tuberculosis in Europe: a systematic review. Thorax 2006; 61: 158-163.
41. Flores L L, Pai M, Colford J M Jr, Riley L W. In-house nucleic acid amplification tests for the detection of Mycobacterium tuberculosis in sputum specimens: meta-analysis and metaregression. BMC Microbiol 2005; 5: 55.
42. Fok A, Numata Y, Schulzer M, Fitz Gerald M J. Risk factors for clustering of tuberculosis cases: a systematic review of population-based molecular epidemiology studies. Int J Tuberc Lung Dis 2008; 12: 480-492.
43. Fontela P S, Pai N P, Schiller I, Dendukuri N, Ramsay A, Pai M. Quality and reporting of diagnostic accuracy studies in TB, HIV and malaria: evaluation using QUADAS and STARD standards. PloS ONE 2009; 4: e7753.
44. Fraser A, Paul M, Attamna A, Leibovici L. Drugs for preventing tuberculosis in people at risk of multiple-drug-resistant pulmonary tuberculosis. Cochrane Database of Systematic Reviews. Chichester, UK: John Wiley & Sons, 2006.
45. Fraser A, Paul M, Attamna A, Leibovici L. Treatment of latent tuberculosis in persons at risk for multidrug-resistant tuberculosis: systematic review. Int J Tuberc Lung Dis 2006; 10: 19-23.
46. Freeman R J, Mancuso J D, Riddle M S, Keep L W. Systematic review and meta-analysis of TST conversion risk in deployed military and long-term civilian travelers. J Travel Med 2010; 17: 233-242.
47. Gao L, Tao Y, Zhang L, Jin Q. Vitamin D receptor genetic polymorphisms and tuberculosis: updated systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14: 15-23.
48. Gao L, Zhou F, Li X W, Jin Q. HIV/TB co-infection in mainland China: a meta-analysis. PloS ONE 2010; 5: e10736.
49. Gao X-F, Li J, Yang Z-W, Li Y-P. Rifapentine vs. rifampicin for the treatment of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2009; 13: 810-819.
50. Gao X-F, Wang L, Liu G-J, et al. Rifampicin plus pyrazinamide versus isoniazid for treating latent tuberculosis infection: a meta-analysis. Int J Tuberc Lung Dis 2006; 10: 1080-1090.
51. Gray D M, Zar H, Cotton M. Impact of tuberculosis preventive therapy on tuberculosis and mortality in HIV-infected children. Cochrane Database Syst Rev 2009; (1): CD006418.
52. Greco S, Rulli M, Girardi E, Piersimoni C, Saltini C. Diagnostic accuracy of in-house PCR for pulmonary tuberculosis in smear-positive patients: meta-analysis and metaregression. J Clin Microbiol 2009; 47: 569-576.
53. Greveson K. Can ELISpot replace the tuberculin skin test for latent tuberculosis? [Provisional abstract]. British J Nurs 2009: 1248-1254.
54. Guo N, Marra F, Marra C A. Measuring health-related quality of life in tuberculosis: a systematic review. Health Qual Life Outcome 2009; 7: 14.
55. Han T. Effectiveness of standard short-course chemotherapy for treating tuberculosis and the impact of drug resistance on its outcome [Structured abstract]. Int J Evid Based Health 2006; 4: 101-117.
56. Hirsch-Moverman Y, Daftary A, Franks J, Colson P W. Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada. Int J Tuberc Lung Dis 2008; 12: 1235-1254.
57. Holty J E C, Gould M K, Meinke L, Keeffe E B, Ruoss S J. Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data. Liver Transpl 2009; 15: 894-906.
58. Horne D J, Royce S E, Gooze L, et al. Sputum monitoring during tuberculosis treatment for predicting outcome: systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 387-294.
59. Houben R, Glynn J R. A systematic review and meta-analysis of molecular epidemiological studies of tuberculosis: development of a new tool to aid interpretation. Trop Med Int Health 2009; 14: 892-909.
60. Houben R M G J, Glynn J R. Systematic review and analysis of population-based molecular epidemiological studies. Int J Tuberc Lung Dis 2009; 13: 275.
61. Jacobson K R, Tierney D B, Jeon C Y, Mitnick C D, Murray M B. Treatment outcomes among patients with extensively drug-resistant tuberculosis: systematic review and meta-analysis. Clin Infect Dis 2010; 51: 6-14.
62. Jeon C Y, Murray M B. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med 2008; 5: 1091-1101.
63. Jiang J, Shi H Z, Liang Q L, Qin S M, Qin X J. Diagnostic value of interferon-gamma in tuberculous pleurisy: a metaanalysis. Chest 2007; 131: 1133-1141.
64. Johnston J C, Shahidi N C, Sadatsafavi M, Fitzgerald J M. Treatment outcomes of multidrug-resistant tuberculosis: a systematic review and meta-analysis. PloS ONE 2009; 4: e6914.
65. Joshi R, Reingold A L, Menzies D, Pai M. Tuberculosis among health-care workers in low-and middle-income countries: a systematic review. PLoS Med 2006; 3: 2376-2391.
66. Jutte P C, Van Loenhout-Rooyackers J H. Routine surgery in addition to chemotherapy for treating spinal tuberculosis. Cochrane Database Syst Rev 2006; (1): CD004532.
67. Kakisi O K, Kechagia A S, Kakisis I K, Rafailidis P I, Falagas M E. Tuberculosis of the oral cavity: a systematic review. Eur J Oral Sci 2010; 118: 103-109.
68. Kalantri S, Pai M, Pascopella L, Riley L, Reingold A. Bacteriophage-based tests for the detection of Mycobacterium tuberculosis in clinical specimens: a systematic review and meta-analysis. BMC Infect Dis 2005; 5: 59.
69. Kangovi S, Mukherjee J, Bohmer R, Fitzmaurice G. A classification and meta-analysis of community-based directly observed therapy programs for tuberculosis treatment in developing countries. J Community Health 2009; 34: 506-513.
70. Kettaneh A, Seng L, Tiev K P, Tolédano C, Fabre B, Cabane J. Human leukocyte antigens and susceptibility to tuberculosis: a meta-analysis of case-control studies. Int J Tuberc Lung Dis 2006; 10: 717-725.
71. Khan F A, Minion J, Pai M, et al. Treatment of active tuberculosis in HIV-coinfected patients: a systematic review and metaanalysis. Clin Infect Dis 2010; 50: 1288-1299.
72. Klinkenberg E, Manissero D, Semenza J C, Verver S. Migrant tuberculosis screening in the EU/EEA: yield, coverage and limitations. Eur Respir J 2009; 34: 1180-1189.
73. Kranzer K, Houben R, Glynn J R, Bekker L G, Wood R, Lawn S D. Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. Lancet Infect Dis 2010; 10: 93-102.
74. Kruk M E, Schwalbe N R, Aguiar C A. Timing of default from tuberculosis treatment: a systematic review. Trop Med Int Health 2008; 13: 703-712.
75. Leone S, Nicastri E, Giglio S, Narciso P, Ippolito G, Acone N. Immune reconstitution inflammatory syndrome associated with Mycobacterium tuberculosis infection: a systematic review. Int J Infect Dis 2010; 14: e283-e91.
76. Lew W, Pai M, Oxlade O, Martin D, Menzies D. Initial drug resistance and tuberculosis treatment outcomes: systematic review and meta-analysis. Ann Intern Med 2008; 149: 123-134.
77. Lewis S J, Baker I, Davey Smith G. Meta-analysis of vitamin D receptor polymorphisms and pulmonary tuberculosis risk. Int J Tuberc Lung Dis 2005; 9: 1174-1177.
78. Li H-T, Zhang T-T, Zhou Y-Q, Huang Q-H, Huang J. SLC11A1 (formerly NRAMP1) gene polymorphisms and tuberculosis susceptibility: a meta-analysis. Int J Tuberc Lung Dis 2006; 10: 3-12.
79. Liang H Y, Li X L, Yu X S, et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009; 125: 2936-2944.
80. Liang Q L, Shi H Z, Wang K, Qjn S M, Qin X J. Diagnostic accuracy of adenosine deaminase in tuberculous pleurisy: a meta-analysis. Respir Med 2008; 102: 744-754.
81. Lin H H, Ezzati M, Murray M. Tobacco smoke, indoor air pollution and tuberculosis: A systematic review and meta-analysis. PLoS Med 2007; 4: 173-189.
82. Lin M-Y, Lin S-J, Chan L-C, Lu Y-C. Impact of food and antacids on the pharmacokinetics of anti-tuberculosis drugs: systematic review and meta-analysis. Int J Tuberc Lung Dis 2010; 14: 806-818.
83. Ling D I, Flores L L, Riley L W, Pai M. Commercial nucleicacid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS ONE 2008; 3: e1536.
84. Ling D I, Zwerling A A, Pai M. Geno Type MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a metaanalysis. Eur Respir J 2008; 32: 1165-1174.
85. Liu Q, Abba K, Alejandria M M, Balanag V M, Berba R P, Lansang M A D. Reminder systems and late patient tracers in the diagnosis and management of tuberculosis. Cochrane Database Syst Rev 2008; (4): CD006594.
86. Liu Q, Garner P, Wang Y, Huang B, Smith H. Drugs and herbs given to prevent hepatotoxicity of tuberculosis therapy: systematic review of ingredients and evaluation studies. BMC Public Health 2008; 8: 365.
87. Lönnroth K, Williams B G, Cegielski P, Dye C. A consistent log-linear relationship between tuberculosis incidence and body mass index. Int J Epidemiol 2010; 39: 149-155.
88. Lönnroth K, Williams B G, Stadlin S, Jaramillo E, Dye C. Alcohol use as a risk factor for tuberculosis-a systematic review. BMC Public Health 2008; 8: 289.
89. Volmink J, Garner P. Intervention for promoting adherence to tuberculosis management. Cochrane Database Syst Rev 2000; (4): CD000010.
90. Martin A, Panaiotov S, Portaels F, Hoffner S, Palomino J C, Angeby K. The nitrate reductase assay for the rapid detection of isoniazid and rifampicin resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2008; 62: 56-64.
91. Martin A, Portaels F, Palomino J C. Colorimetric redoxindicator methods for the rapid detection of multidrug resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis. J Antimicrob Chemother 2007; 59: 175-183.
92. Mase S R, Ramsay A, Ng V, et al. Yield of serial sputum specimen examinations in the diagnosis of pulmonary tuberculosis: a systematic review. Int J Tuberc Lung Dis 2007; 11: 485-495.
93. Menon P R, Lodha R, Sivanandan S, Kabra S K. Intermittent or daily short course chemotherapy for tuberculosis in children: meta-analysis of randomized controlled trials. Indian Pediatr 2010; 47: 67-73.
94. Menzies D, Benedetti A, Paydar A, et al. Effect of duration and intermittency of rifampin on tuberculosis treatment outcomes: a systematic review and meta-analysis. PLoS Med 2009; 6: e1000146.
95. Menzies D, Benedetti A, Paydar A, et al. Standardized treatment of active tuberculosis in patients with previous treatment and/or with mono-resistance to isoniazid: a systematic review and meta-analysis. PLoS Med 2009; 6: e1000150.
96. Menzies D, Pai M, Comstock G. Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research. Ann Intern Med 2007; 146: 340-354.
97. Millership S E, Anderson C, Cummins A J, Bracebridge S, Abubakar I. The risk to infants from nosocomial exposure to tuberculosis. Pediatr Infect Dis J 2009; 28: 915-916.
98. Minion J, Pai M. Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. Int J Tuberc Lung Dis 2010; 14: 941-951.
99. Morgan M, Kalantri S, Flores L, Pai M. A commercial line probe assay for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a systematic review and metaanalysis. BMC Infect Dis 2005; 5: 62.
100. Morisson P, Neves D D. Evaluation of adenosine deaminase in the diagnosis of pleural tuberculosis: a Brazilian metaanalysis. J Bras Pneumol 2008; 34: 217-224.
101. Morrison J, Pai M, Hopewell P C. Tuberculosis and latent tuberculosis infection in close contacts of people with pulmonary tuberculosis in low-income and middle-income countries: a systematic review and meta-analysis. Lancet Infect Dis 2008; 8: 359-368.
102. Munro S A, Lewin S A, Smith H J, Engel M E, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med 2007; 4: 1230-1245.
103. Murphy D J, Brown J R. Identification of gene targets against dormant phase Mycobacterium tuberculosis infections. BMC Infect Dis 2007; 7: 84.
104. Nava-Aguilera E, Andersson N, Harris E, et al. Risk factors associated with recent transmission of tuberculosis: systematic review and meta-analysis. Int J Tuberc Lung Dis 2009; 13: 17-26.
105. Nnoaham K E, Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol 2008; 29: 113-119.
106. Noyes J, Popay J. Directly observed therapy and tuberculosis: how can a systematic review of qualitative research contribute to improving services? A qualitative meta-synthesis. J Adv Nurs 2007; 57: 227-243.
107. Obihara C C, Bollen C W, Beyers N, Kimpen J L L. Mycobacterial infection and atopy in childhood: a systematic review. Pediatr Allergy Immunol 2007; 18: 551-559.
108. Orenstein E W, Basu S, Shah N S, et al. Treatment outcomes among patients with multidrug-resistant tuberculosis: systematic review and meta-analysis. Lancet Infect Dis 2009; 9: 153-161.
109. Pacheco A G, Cardoso C C, Moraes M O. IFNG +874T/A, IL10-1082G/A and TNF-308G/A polymorphisms in association with tuberculosis susceptibility: a meta-analysis study. Human Genetics 2008; 123: 477-484.
110. Pai M, Kalantri S, Pascopella L, Riley L W, Reingold A L. Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a metaanalysis. J Infect 2005; 51: 175-187.
111. Pai M, Zwerling A, Menzies D. Systematic review: T-cellbased assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008; 149: 177-184.
112. Pasipanodya J G, Gumbo T. Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used. Antimicrob Agents Chemother 2010; 54: 2847-2854.
113. Payne B, Bellamy R. Tuberculosis in people with HIV. Clin Evid (Online) 2007; 6: 920.
114. Pereira S M, Dantas O M S, Ximenes R, Barreto M L. [BCG vaccine against tuberculosis: its protective effect and vaccination policies]. Rev Saúde Publica 2007; 41 (Suppl 1): 59-66. [Portuguese]
115. Piersimoni C, Olivieri A, Benacchio L, Scarparo C. Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems. J Clin Microbiol 2006; 44: 20-28.
116. Placidi D, Tonozzi B, Alessio L, Porru S. [Tuberculin skin test (TST) survey among healthcare workers (HCWs) in hospital: a systematic review of the literature]. Giornale Italiano di Medicina del Lavoro Ed Ergonomia 2007; 29: 409-411. [ Italian]
117. Prasad K, Singh M B. Corticosteroids for managing tuberculous meningitis. Cochrane Database Syst Rev 2008; 1: CD002244.
118. Rajagopala S, Agarwal R. Tubercular mastitis in men: case report and systematic review. Am J Med 2008; 121: 539-544.
119. Rehm J, Samokhvalov A V, Neuman M G, et al. The association between alcohol use, alcohol use disorders and tuberculosis (TB). A systematic review. BMC Public Health 2009; 9: 450.
120. Riquelme A, Calvo M, Salech F, et al. Value of adenosine deaminase (ADA) in ascitic fluid for the diagnosis of tuberculous peritonitis-a meta-analysis. J Clin Gastroenterol 2006; 40: 705-710.
121. Sanai F M, Bzeizi K I. Systematic review: tuberculous peritonitis- presenting features, diagnostic strategies and treatment. Aliment Pharmacol Ther 2005; 22: 685-700.
122. Setia M S, Steinmaus C, Ho C S, Rutherford G W. The role of BCG in prevention of leprosy: a meta-analysis. Lancet Infect Dis 2006; 6: 162-170.
123. Slama K, Chiang C-Y, Enarson D A, et al. Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis 2007; 11: 1049-1061.
124. Slama K, Chiang C-Y, Hinderaker S G, Bruce N, Vedal S, Enarson D A. Indoor solid fuel combustion and tuberculosis: is there an association? Int J Tuberc Lung Dis 2010; 14: 6-14.
125. Sotgiu G, Ferrara G, Matteelli A, et al. Epidemiology and clinical management of XDR-TB: a systematic review by TBNET. Eur Respir J 2009; 33: 871-881.
126. Sreeramareddy C T, Panduru K V, Menten J, Van den Ende J. Time delays in diagnosis of pulmonary tuberculosis: a systematic review of literature. BMC Infect Dis 2009; 9: 91.
127. Steingart K, Henry M, Ng V, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-581.
128. Steingart K R, Dendukuri N, Henry M, et al. Performance of purified antigens for serodiagnosis of pulmonary tuberculosis: a meta-analysis. Clin Vaccine Immunol 2009; 16: 260-276.
129. Steingart K R, Henry M, Laal S, et al. A systematic review of commercial serological antibody detection tests for the diagnosis of extra-pulmonary tuberculosis. Postgrad Med J 2007; 83: 705-712.
130. Steingart K R, Henry M, Laal S, et al. Commercial serological antibody detection tests for the diagnosis of pulmonary tuberculosis: a systematic review. PLoS Med 2007; 4: 1041-1060.
131. Steingart K R, Ng V, Henry M, et al. Sputum processing methods to improve the sensitivity of smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 664-674.
132. Storla D G, Yimer S, Bjune G A. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health 2008; 8: 15.
133. Suchindran S, Brouwer E S, Van Rie A. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PloS ONE 2009; 4: e5561.
134. Sun F, Chen Y, Xiang Y, Zhan S. Drug-metabolising enzyme polymorphisms and predisposition to anti-tuberculosis druginduced liver injury: a meta-analysis. Int J Tuberc Lung Dis 2008; 12: 994-1002.
135. Trunz B B, Fine P, Dye C. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet 2006; 367: 1173-1180.
136. Tuon F F, Higashino H R, Lopes M I B F, et al. Adenosine deaminase and tuberculous meningitis: a systematic review with meta-analysis. Scand J Infect Dis 2010; 42: 198-207.
137. Tuon F F, Litvoc M N, Lopes M. Adenosine deaminase and tuberculous pericarditis-a systematic review with metaanalysis. Acta Tropica 2006; 99: 67-74.
138. van Zyl-Smit R N, Zwerling A, Dheda K, Pai M. Withinsubject variability of interferon-g assay results for tuberculosis and boosting effect of tuberculin skin testing: a systematic review. PloS ONE 2009; 4: e8517.
139. Vassall A, Compernolle P. Estimating the resource needs of scaling-up HIV/AIDS and tuberculosis interventions in sub-Saharan Africa: a systematic review for national policy makers and planners. Health Policy 2006; 79: 1-15.
140. Vlassov V V, Pechatnikov L M, MacLehose H G. Low level laser therapy for treating tuberculosis. Cochrane Database Syst Rev 2002; (3): CD003190.
141. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev 2006; (2): CD003343.
142. Wisnivesky J P, Serebrisky D, Moore C, Sacks H S, Iannuzzi M C, McGinn T. Validity of clinical prediction rules for isolating inpatients with suspected tuberculosis: a systematic review. J Gen Internal Med 2005; 20: 947-952.
143. Yang X Y, Chen Q F, Cui X H, Yu Y, Li Y P. Mycobacterium vaccae vaccine to prevent tuberculosis in high risk people: a meta-analysis. J Infection 2010; 60: 320-330.
144. Ziakas P D, Mylonakis E. 4 months of rifampin compared with 9 months of isoniazid for the management of latent tuberculosis infection: a meta-analysis and cost-effectiveness study that focuses on compliance and liver toxicity. Clin Infect Dis 2009; 49: 1883-1889.
145. Ziganshina L E, Garner P. Tuberculosis (HIV-negative people). Clin Evid (Online) 2009; 1 Apr 14.
146. Ziganshina L E, Squire S B. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 2008; (1): CD004795.
147. Ziganshina L E, Vizel A A, Squire S B. Fluoroquinolones for treating tuberculosis. Cochrane Database Syst Rev 2005; (3): CD004795.
148. Zodpey S P. Protective effect of bacillus Calmette Guerin (BCG) vaccine in the prevention of leprosy: a meta-analysis. Indian J Dermatol Venereol Leprol 2007; 73: 86-93.
149. Pai M, Minion J, Steingart K, Ramsay A. New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 2010; 16: 271-284.
150. Gallardo C R, Rigau D, Irfan A, et al. Quality of tuberculosis guidelines: urgent need for improvement. Int J Tuberc Lung Dis 2010; 14: 1045-1051.
151. Jadad A R, Cook D J, Jones A, et al. Methodology and reports of systematic reviews and meta-analyses: a comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998; 280: 278-280.
152. Steingart K R, Sohn H, Schiller I, et al. Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev 2013; 1: CD009593.